The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era

A Mocroft, H J Furrer, J M Miro, P Reiss, C Mussini, O Kirk, S Abgrall, S Ayayi, B Bartmeyer, D Braun, A Castagna, A d'Arminio Monforte, B Gazzard, F Gutierrez, I Hurtado, Karina Jansen, L Meyer, P Muñoz, N Obel, P Soler-PalacinA Papadopoulos, F Raffi, J T Ramos, J K Rockstroh, D Salmon, C Torti, J Warszawski, S de Wit, R Zangerle, C Fabre-Colin, J Kjaer, G Chene, Jesper Grarup, J D Lundgren, Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD

    91 Citationer (Scopus)

    Abstract

    Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring and resource allocation.
    OriginalsprogEngelsk
    TidsskriftClinical infectious diseases : an official publication of the Infectious Diseases Society of America
    Vol/bind57
    Udgave nummer7
    Sider (fra-til)1038-47
    Antal sider10
    ISSN1058-4838
    DOI
    StatusUdgivet - okt. 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era'. Sammen danner de et unikt fingeraftryk.

    Citationsformater